key: cord-0837536-0vttye8w
authors: Hussen, Bashdar Mahmud; Sabir, Dana Khdr; Karim, Yasin; Karim, Karzan Khawaraham; Hidayat, Hazha Jamal
title: Genome sequence analysis of SARS-COV-2 isolated from a COVID-19 patient in Erbil, Iraq
date: 2022-02-07
journal: Appl Nanosci
DOI: 10.1007/s13204-021-02300-w
sha: 347cb5ddd995d317e2384f3f3789499c01d5f6fd
doc_id: 837536
cord_uid: 0vttye8w

In the city of Wuhan, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first recognized among humans at the end of December 2019, and has since spread to every country around the world. The emergence of this new coronavirus has attracted global attention to work towards finding a treatment and developing an effective vaccine against the virus. In this study, we sequence a full genome of SARS-COV-2 isolated from a male patient in the city of Erbil, Iraq. The virus was sequenced using Sanger sequencer and 21 distinct mutations were found in our isolate compared to the full genome sequence of the SARS-COV-2 isolated from the city of Wuhan/China (Accession number: NC_045512.2). Sequence analysis showed that four of the mutations were located at the spike glycoprotein (S), and ten of them were in nonstructural proteins (nsp1, nsp3, nsp12, and orf3a), which had been shown to be related to structural changes at various sites. Moreover, phylogenetic analysis and transmission supported the conclusion that the cases in Iraq were of independent origins of infections and had a close relation to the isolates from Iran. This is the first report on the DNA sequence of the SARS-CoV-2 genome isolated from the Kurdistan region of Iraq.

The recent appearance of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has attracted global attention and prompted an international campaign to develop a treatment and vaccine. The outbreak began in Wuhan, China, in December 2019 (Zhu et al. 2020 ) and has since spread to every country and impacting virtually everyone in the world (Hussen et al. 2021a ). Since April 19, 2021, there have been 140,886,773 confirmed cases of COVID-19, with 3,012,251 deaths reported.

The SARS-CoV-2 virus is an enveloped single-stranded positive-sense RNA (+ ssRNA), encoding around 9860 amino acids (Kim et al. 2020; Sabir et al. 2020) . Typical SARS-CoV-2 has one of the largest genomes ∼ 30 kb, among all RNA virus families (Sidiq et al. 2020) (Fig. 1) .

Efforts to develop successful vaccines have been separately undertaken in response to the pandemic's urgency. However, like other pathogens, staying in a hospital or living in a crowded place makes it easier for viruses to spread (Saleh et al. 2021; Ali et al. 2020; Al-Sa'ady et al. 2020; Mostafaei et al. 2021; Al-Bdery et al. 2020 ) and as a response to this, self-quarantine has been shown to have a negative impact which disturbs the lifestyle (Hussen et al. 2021b ). Viral genome sequences from different countries can assist in determining the virus's mutational tendencies as it crosses diverse geographical environments and peoples of various cultures, with differing genetic profiles and immunological responses (Parlikar et al. 2020; Khailany et al. 2020) . Therefore, whole viral genome sequencing is important for diagnosing viral infectious diseases and developing vaccines. In addition, genome sequencing could be used to study the virulence and pathogenicity of the virus, as well as the evolutionary linkages between hosts and viruses (Shaibu et al. 2021) . SARS-CoV-2 is rapidly spreading through countries, and there has been considerable concern about whether the spread is due to mutations in the virus (Aldiabat et al. 2018; Alhayani and llhan 2021) .

A significant feature of this virus is its high mutation rate, with recent studies showing that, the viral genome develops new mutations as it spreads through various environments (Pachetti et al. 2020; Junejo et al. 2020; Khailany et al. 2020) . As an RNA virus, SARS-CoV-2 does not have a 'proof reading' function when it replicates, and so random mutations occur. These have become quite prolific and are the primary circulating forms of the virus in many areas Hasan and Alhayani 2021) . ORF1ab, ORF3a, ORF8, N, M, and S regions have all been found to have mutations, with nt8782 in ORF 1a and nt28144 ORF 8 showed mutation rate of 29.47% and 30.53%, respectively Hasan and Alhayani 2021; Mohammed and Daham 2021) . In addition, it is believed that nucleotide variations, one of the most important indicators of viral development, are also responsible for modifying the virus in all conditions (Mostafaei et al. 2021; Hui 2006; Domingo 2000; Taheri et al. 2021; Ibrahim et al. 2021; Khan et al. 2021) .

The main aim of this study was to carry out wholegenome sequencing (WGS) of the local SARS-CoV2 variant to gain insights into the mutational variation of the virus compared to the first reported genome sequence of the SARS-COVID-2 genome isolated from Wuhan/China. In addition, this sequencing enabled a precise understanding of the novel variations, which are key indicators for viral development and vaccine response.

This study was approved by the Medical Research Centre (MRC) ethical committee (Application number: IRB-20-357) at Hawler Medical University, Erbil, Iraq.

A nasopharyngeal swab collected from a patient (28-yearold male with respiratory tract infection in Erbil) received at the Immunogene Center for COVID-19 testing in December 2020 was used in this study. Viral nucleic acid extraction was performed using a QIamp RNA extraction kit (Qiagen, Maryland, USA) as per manufacturer recommendations. Viral presence was detected by using a Luna universal probe one-stage RT-qPCR kit (NEB, MA, USA) using primers and probes targeting nucleocapsid viral gene (Corman et al. 2019) . 

Complementary DNA (cDNA) was synthesized from extracted RNA from a clinical sample that was positive for SARS-CoV-2. cDNA was then PCR amplified using a set of primers to obtain overlapping segments of the whole viral genome. High-performance sequencing was performed using a normal protocol Sanger sequencing (Applied Biosystems 3130xl genetic analyzer) according to the manufacturer's standards with a 150 bp read length. The assembly of the genome took place using MEGAHIT v1.2.9 (Li et al. 2015) . Genome assembly was shown using MEGAHIT v1.2.9 (Sidiq et al. 2020) , and the genome size was 29,803 bp and being 99% identical to the Wuhan sequence (NC_045512.2).

The software ClustalW was used to analyze the uniqueness of the sequenced genomes and to align full sequences of the genome to the SARS-CoV-2 reference genome (NC 045512.2) A phylogenetic analysis was done using Molecular Evolutionary Genetics Analysis version 7.0 (MEGA 7.0) to examine similarities and differences between the Erbil genome sequence and 27 SARS-CoV-2 genome sequence downloaded from GenBank and the GISAID database (Elbe and Buckland-Merrett 2017) (Fig. 2 ).

Phylogenetic analysis based on nearly full gene sequence of SARS-COV-2 isolated from different geographical locations. The sequence was downloaded from GenBank and the GISAID database websites. The neighbor-joining method, bootstrapped with 1,000 replicate runs, was used to sequence analysis of the viruses by MEGA 7 tree-building program. The newly sequenced local isolate was highlighted orange on the tree. The accession number and EPI accession number are written next to the name of the country which the virus was isolated. The bar indicates substitutions per nucleotide

The computation model structure of the SARS-COV-2 genome was created using the online service of the SIB Swiss Institute of Bioinformatics (Expasy) database (https:// swiss model. expasy. org/ inter active). The 3S structure of SARS-COV-2 served as a template and was downloaded from Protein Data Bank (Pdb: 6vsb). UCSF Chimera 1.11.2 software was used throughout the investigation of the model structure (Pettersen et al. 2004 ).

The ongoing SARS-CoV-2 epidemic is causing concern around the world due to its extreme contagiousness. Coronaviruses, contain the largest known RNA viruses (26.4 to 31.7 kb) (Woo et al. 2009; Mihindukulasuriya et al. 2008) . A larger genome size offers greater possibilities for genetic modification (Woo et al. 2009; Mihindukulasuriya et al. 2008) . RNA viruses often have extremely high mutation rates, making them very virulent and resulting in the development of new species and changes in the mortality rate and symptoms of host (Duffy 2018; Angeletti et al. 2020 ). This study uncovered several important facts that fill knowledge gaps in relation to the novel COVID-2019 virus (Barzinjy et al. 2021) .

For genome analysis, our isolated genome sequence of the virus strain was uploaded to the NCBI databases accession number MW633517 on February 25, 2021. SARS-CoV-2 isolate sequences were aligned to a reference sequence (NC 045512.2) from Wuhan to identify mutations and the location of the mutations was predicted using the program ClustalW.

Based on mutation analysis, our isolate from Erbil-Iraq contained 21 various silent and missense mutations (Table 1) . Nine mutations were highlighted as unique in the viral SARS-COV-2 isolate compared to the Wuhan reference sequence (Fig. 1) . Of these nine mutations, three of them were identified in the spike glycoprotein (S), one in the Nucleocapsid protein (N), and five in nonstructural proteins (nsp1, nsp3, nsp12, and orf3a), which have been shown to be related to structural changes at various sites. Three of these (L22917R, E23311D, D23403G) lead to alterations in the structure of the spike glycoprotein (S), while the others change the structure of nsp2 (Table1).

Synonymous and non-synonymous mutations were observed in ORF1ab, spike glycoprotein (S), ORF3a, Membrane glycoprotein (M), and Nucleocapsid protein (N), but none were observed in ORF6, ORF7a, ORF7b, ORF8, or ORF10 gene. These co-occurring mutations were recently identified as a feature of one of the major SARS-CoV-2 variants found in Europe.

In the ORF1ab region, we found ten variations, which include both unique and previously described mutations at position 269 (G > A), 3037 (C > T), 5832 (C > T), 6293 (A > G), 7675 (GG > CT), 11152 (C > T), 12142 (T > A), 14408 (C > T), 16524 (A > G) and 18877 (C > T).

ORF1ab has multiple functions, influencing helicase activity, RNA-dependent RNA polymerase activity, methyltransferase activity, Zn-binding, and Fe-S cluster binding activity (Graham et al. 2008) . The functional consequences of such mutations are yet unknown and future studies on functional alterations produced by such mutations may improve better understanding of viral pathogenesis.

Based on existing knowledge, mutations in nonstructural protein 1 (nsp1) at position 269 G > A (E2L) nsp1 and I2010V at position 6293nsp3 are unique and not previously described as non-synonymous mutations in SARS-CoV-2 nsp1 which exhibits a much higher capacity to block the host proteins synthesis, this may enhance the pathogenicity of SARS-CoV-2 (Shen et al. 2021) .

The 14408 C > T (P4715L) and 3037 C > T variations in ORF1ab were reported to be common in neighboring countries and are thought to be related to and to have a causative role in, mutations in the RNAdependent RNA polymerase (RdRP/nsp12) and nsp3 genes, respectively. Because RdRP/nsp12 is a core part of the replication or transcription process, the leucine mutation at position 14408 of RdRP/nsp12 may alter its function, ultimately increasing the mutation rate of the virus (Eskier et al. 2020) .

Furthermore, the proline-to-leucine mutation has been identified as a prevalent mutation in earlier studies in Turkey , Europe (51.6%) (Pachetti et al. 2020) and North America (58.1%) (Banerjee et al. 2021 ).

In addition, C3037T variation has been linked to a synonymous mutation in the region coding for nsp3 (nonstructural protein) and was observed in (71%) of Turkey. In humans, nsp2 and nsp3 are known to play important roles in SARS-CoV-2 pathogenesis (Angeletti et al. 2020) .

Other mutations found in this study includes at one position 25440G > T (K16N) and another (Q57H) at position 25,563G > T within the region of ORF3a, which was seen in Turkish isolates and, one variation at position 26735 (C > T) in the M protein also was seen.

Similarly, one study (Omotoso et al. 2021) previously described a non-synonymous mutation at position 28854C > T (S194L), and in the current study such a mutation was observed in the N protein, which altered the original sequence of the open reading frame for the nucleocapsid (N) protein which is recognized to be important in virion assembly and structure (Weber et al. 2021) . Apart from frequent mutations, four variants were found in the spike glycoprotein (S); while triple mutations observed (L452R, E583D, D614G) were non-synonymous and were reported previously in strains from other countries (Harvey et al. 2021) (Fig. 2) .

The L452R mutation, which changes the amino acid Leucine (L) to Arginine (R) at position 22917, is the main change at receptor binding domain (RBD) that inhibit the Spike glycoprotein's reactivity, so that it become resistant to neutralizing antibodies in the sera of patients Greaney et al. 2021) . Additionally, the RBD binding site alterations enhance the free energy of the direct interaction with ACE2 to form RBD-ACE2 binding complex that makes viral attachment to cells more probable and, thus, increases viral infectivity Tchesnokova et al. 2021) .

The second mutation detected in the spike glycoprotein (S) is E583D, which is located in the S1 domain and was previously detected in Asia (Das et al. 2021) . Signal peptide mutations might affect signaling processes within the intracellular secretory route, but the meaning behind these changes is yet to be defined.

The mutation is D614G, which modifies the amino acid aspartate (D) with a polar negative charged side chain to the amino acid glycine (G) with a non-polar side chain, is one of the most common mutations of SARS-CoV-2, and it was first found in China on January 24, 2020 (Wang et al. 2021) .

The amino acids surrounding position 614 are quite conservative, showing that the D614G mutation will have a significant effect on the S protein functions of SARS-CoV-2.

The D614G mutation has been identified as the primary mutation responsible for the increased infectiousness of SARS-CoV-2 on a global scale (Korber et al. 2020; Yurkovetskiy et al. 2020) .

Finally, the genome sequence of the located sequenced SARS-COV-2 was compared to genome sequences from Saudi Arabia, Turkey, Iran, America, China, and some European countries (Fig. 3) .

The phylogenetic tree was built based on the neighborjoining method in MEGA 7 software (Kumar et al. 2016) . The result shows how closely related our isolate is to previously sequenced SARS-COV-2 genome, such as from a male patient from the city of Shiraz/Iran (EPI Accession number: EPI_ISL_2455558). Considering, the close proximity of Iran and Iraq, perhaps it is not surprising that the variant of SARS-COV-2 found in Erbil originated from Iran. Notably, the collection date of the reported sample was in January, 25th, 2021.

In this study, we sequenced one SARS-CoV-2 genome from a clinical sample collected from Erbil, Iraq. Additional mutations and previously known mutations (synonymous and non-synonymous) were found in genome assembly and annotation research. We identified positionspecific mutations in the nucleotide sequences, such as single-nucleotide variants. Additional analysis is performed on amino acid substitutions to determine the functional stability of the proteins. Our findings showed that SARS-CoV-2 proteins have 21 different variant locations in their coding regions. ORF1ab is the protein with the most mutations, followed by three structural proteins (S, ORF3a, N). We found fewer mutations in ORF3a and N proteins than in ORF1ab and S proteins. A higher quantity of single point mutation, C > T, is observed both in the second and 3rd positions in the codons.

Through analyzing the viral genome's phylogeny, it was discovered that they share many similarities with isolates that were found in Turkey, Saudi Arabia, and the United States, indicating that several introductions to the state may have occurred. To gain a better understanding of the possible function in terms of virulence, infectivity, and virus release, a complete investigation would be useful.

Funding The authors received no funding and the study is self-funded.

Conflict of interest All authors declare that they have no conflict of interest.

Location of non-synonymous mutation in the SARS-COV-2 Spike protein. A Trimer model structure of the SARS-COV-2 created using Expasy proteomic database based on the 3D structure of SARS-COV-2 (Pdb: 6vsb). B Visualizing the ribbon diagram of SARS-COV-2 S-protein using UCSF Chimera software. C Location of the three mutations R542, D538, and G164 on the model structure of Spike S protein are colored red

Vancomycin and linezolid resistance among multidrug-resistant Staphylococcus aureus clinical isolates and interaction with neutrophils

The extent of smartphones users to adopt the use of cloud storage

Visual sensor intelligent module based image transmission in industrial manufacturing for monitoring and manipulation problems

Intelligent secured two-way image transmission using corvus corone module over WSN

Molecular detection of bla ctx-m gene among pseudomonas aeruginosa strains isolated from different clinical samples in erbil city

Genetic relation and virulence factors of carbapenemase-producing Uropathogenic Escherichia coli from urinary tract infections in Iraq

COVID-2019: the role of the nsp2 and nsp3 in its pathogenesis

Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America

Fear of COVID-19 as a precautionary measure to prevent the epidemic among the population of the Kurdistan Region/ Iraq: based on a questionnaire survey

Mutations strengthened SARS-CoV-2 infectivity

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Characterizing genomic variants and mutations in SARS-CoV-2 proteins from Indian isolates

Viruses at the edge of adaptation

Why are RNA virus mutation rates so damn high?

Data, disease and diplomacy: GISAID's innovative contribution to global health

RdRp mutations are associated with SARS-CoV-2 genome evolution

SARS coronavirus replicase proteins in pathogenesis

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

SARS-CoV-2 variants, spike mutations and immune escape

Novel unilateral dental expander appliance (udex): a compound innovative materials

Reasons for the increase in emerging and re-emerging viral infectious diseases

The assessment of lifestyle change due to COVID-19 pandemic in northern Iraq

Impact of mass media on the population as a precautionary prevention from COVID-19 in Iraq

Chemistry of selected drugs for SARS-CoV-2 inhibition: tested in vitro and approved by the FDA

Novel SARS-CoV-2/COVID-19: origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic analysis

Genomic characterization of a novel SARS-CoV-2

Exploring the interaction of quercetin-3-O-sophoroside with SARS-CoV-2 main proteins by theoretical studies: a probable prelude to control some variants of coronavirus including Delta

The architecture of SARS-CoV-2 transcriptome

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus

MEGA7: molecular evolutionary genetics analysis Version 7.0 for bigger datasets

MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph

The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity

Identification of a novel coronavirus from a beluga whale by using a panviral microarray

Analytic hierarchy process for evaluating flipped classroom learning

The role of viral and bacterial infections in the pathogenesis of IPF: a systematic review and meta-analysis

Mutational hotspots and conserved domains of SARS-CoV-2 genome in African population

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant

Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2

UCSF Chimera-a visualization system for exploratory research and analysis

Identification of novel mutations in SARS-COV-2 isolates from Turkey

Children protection against COVID-19 at the pandemic outbreak

High diversity of virulent and multidrug-resistant Stenotrophomonas maltophilia in Iraq

Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria

Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression

Does early childhood vaccination protect against COVID-19?

Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients

Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants

The establishment of reference sequence for SARS-CoV-2 and variation analysis

Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants

Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world

Comparative analysis of complete genome sequences of three avian coronaviruses reveals a novel group 3c coronavirus

Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant

A novel coronavirus from patients with pneumonia in China